Valuation : Universal Vision Biotechnology Co., Ltd.

Market Cap 11.73B 371M 319M 299M 273M 515M 35.42B 516M 3.55B 1.39B 17.88B 1.39B 1.36B 59.28B P/E 2026 *
10.3x
P/E 2027 * -
Enterprise Value 11.73B 371M 319M 299M 273M 515M 35.42B 516M 3.55B 1.39B 17.88B 1.39B 1.36B 59.28B EV / Sales 2026 *
2.76x
EV / Sales 2027 * 2.64x
Free-Float
47.64%
Yield 2026 *
5.8%
Yield 2027 * -
08-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-04 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 22, 2026 CI
11-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-12 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-05 Universal Vision Biotechnology Co., Ltd. announces Annual dividend, payable on April 21, 2025 CI
24-11-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-11 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-09 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-13 Universal Vision Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
1 day+0.73%
1 week+1.09%
Current month+4.53%
1 month+1.84%
3 months+6.13%
6 months+1.47%
Current year-5.14%
1 week 134
Extreme 134
139.5
1 month 131
Extreme 131
147
Current year 122
Extreme 122
154
1 year 122
Extreme 122
181.5
3 years 122
Extreme 122
352.5
5 years 122
Extreme 122
432.08
10 years 18.64
Extreme 18.643305
432.08
Manager TitleAgeSince
Chief Executive Officer - 2010-01-31
Director of Finance/CFO - 2016-03-31
President - -
Director TitleAgeSince
Chairman - 2012-06-27
Director/Board Member - 2003-06-01
Director/Board Member 66 2012-06-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.73%+1.09%-23.69%-56.51% 371M
+2.44%-1.13%-38.74%-8.39% 86.06B
-0.96%-1.53%-9.19%-21.93% 34.64B
+0.30%-6.63%+10.20%-23.75% 13.88B
-0.69%-3.82% - - 11.57B
+3.08%+13.86%-6.65%+731.81% 2.81B
-0.81%-0.36%-39.91%-57.19% 1.46B
+0.53%+1.34%+17.08%+12.87% 914M
-1.89%-0.34% - - 884M
-1.45%-0.61%-40.45%-14.39% 873M
Average +0.13%+1.17%-16.42%+70.32% 15.35B
Weighted average by Cap. +1.16%-1.57%-25.65%+0.99%

Financials

2026 *2027 *
Net sales 4.25B 134M 116M 108M 99.02M 187M 12.83B 187M 1.29B 502M 6.48B 504M 493M 21.48B 4.44B 140M 121M 113M 103M 195M 13.4B 195M 1.34B 524M 6.77B 527M 515M 22.43B
Net income 1.14B 36.06M 31.08M 29.14M 26.6M 50.11M 3.45B 50.27M 346M 135M 1.74B 135M 132M 5.77B -
Net Debt - -
Logo Universal Vision Biotechnology Co., Ltd.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
Employees
401
Date Price Change Volume
26-08-28 NT$138.50 +0.73% 141,543
26-08-27 NT$137.50 0.00% 206,157
26-08-26 NT$137.50 +2.23% 106,619
26-08-25 NT$134.50 -0.74% 214,577
26-08-24 NT$135.50 -1.09% 88,306
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
138.50TWD
Average target price
150.00TWD
Spread / Average Target
+8.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3218 Stock